ZJM-29010-95415
3 vaccinations
2 coded responses
36 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 430 / OH
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
7FM-85302-32875
Child or adolescent in my care · Female · 2021-11-05
CFS-40577-87412
Child or adolescent in my care · Female · 2021-11-05
7N2-25218-85053
Child or adolescent in my care · Male · 2022-06-27
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
- 2020-12-31
- 2021-01-01
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-03
-
2021-01-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-14
- 2021-01-21
-
2021-01-28
Dose 2 — Moderna
-
2021-01-28
Survey response — day 0, dose 2MedDRA: Paraesthesia oral — Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tirednessFree text: Mild tingling to the tongueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, NauseaAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-13
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-04-29
- 2021-07-29
-
2021-11-05
Dose 3 — Moderna
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-07
- 2021-11-10
- 2021-11-13
- 2021-11-19
- 2021-12-09
- 2021-12-13
- 2021-12-17
- 2022-02-04
- 2022-05-06
-
2022-11-05
Survey response — 12 months, dose 3MedDRA: Gallbladder disorder — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Gallbladder disease (removal scheduled for next week)MedDRA releases: 2024-11 · check-in free text available
-
2022-11-05
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2022-11-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-28 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-05 | Unsuccessful |
Free text
Release 2 — day 0, dose 2
Systemic reaction (other): Mild tingling to the tongue
Release 12 — 12 months, dose 3
Symptoms: Gallbladder disease (removal scheduled for next week)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gallbladder disorder | · | · | ✓ |
| SRO | Paraesthesia oral | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release